PortfoliosLab logoPortfoliosLab logo
OSUR vs. MED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OSUR vs. MED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in OraSure Technologies, Inc. (OSUR) and Medifast, Inc. (MED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OSUR achieves a 71.90% return, which is significantly higher than MED's 3.18% return. Over the past 10 years, OSUR has outperformed MED with an annualized return of -4.53%, while MED has yielded a comparatively lower -7.79% annualized return.


OSUR

1D
-2.12%
1M
15.24%
YTD
71.90%
6M
72.61%
1Y
38.67%
3Y*
-6.63%
5Y*
-15.45%
10Y*
-4.53%

MED

1D
-0.18%
1M
-12.47%
YTD
3.18%
6M
-2.74%
1Y
-22.01%
3Y*
-49.36%
5Y*
-46.41%
10Y*
-7.79%
*Multi-year figures are annualized to reflect compound growth (CAGR)

OSUR vs. MED - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
OSUR
OraSure Technologies, Inc.
71.90%-32.96%-55.98%70.12%-44.53%-17.90%31.82%-31.25%-38.07%114.81%
MED
Medifast, Inc.
3.18%-39.39%-73.79%-38.34%-42.31%9.36%86.18%-9.73%82.11%72.33%

Correlation

The correlation between OSUR and MED is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Dec 31, 1993

0.18

The correlation between OSUR and MED shifts across timeframes, from 0.12 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

OSUR:

$289.85M

MED:

$121.29M

EPS

OSUR:

-$0.73

MED:

-$1.82

PS Ratio

OSUR:

3.53

MED:

0.35

Total Revenue (TTM)

OSUR:

$85.12M

MED:

$346.10M

Gross Profit (TTM)

OSUR:

$33.04M

MED:

$242.70M

EBITDA (TTM)

OSUR:

-$47.07M

MED:

-$3.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OSUR vs. MED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OSUR
OSUR Risk / Return Rank: 6464
Overall Rank
OSUR Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
OSUR Sortino Ratio Rank: 6666
Sortino Ratio Rank
OSUR Omega Ratio Rank: 6262
Omega Ratio Rank
OSUR Calmar Ratio Rank: 6363
Calmar Ratio Rank
OSUR Martin Ratio Rank: 6363
Martin Ratio Rank

MED
MED Risk / Return Rank: 1919
Overall Rank
MED Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
MED Sortino Ratio Rank: 1717
Sortino Ratio Rank
MED Omega Ratio Rank: 1919
Omega Ratio Rank
MED Calmar Ratio Rank: 2020
Calmar Ratio Rank
MED Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OSUR vs. MED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for OraSure Technologies, Inc. (OSUR) and Medifast, Inc. (MED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


OSURMEDDifference
Sharpe ratioReturn per unit of total volatility

+1.33

Sortino ratioReturn per unit of downside risk

+2.08

Omega ratioGain probability vs. loss probability

1.17

0.93

+0.24

Calmar ratioReturn relative to maximum drawdown

0.99

-0.59

+1.58

Martin ratioReturn relative to average drawdown

2.22

-1.00

+3.22

OSUR vs. MED - Sharpe Ratio Comparison

The current OSUR Sharpe Ratio is 0.80, which is higher than the MED Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of OSUR and MED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

OSUR vs. MED - Drawdown Comparison

The maximum OSUR drawdown since its inception was -90.75%, smaller than the maximum MED drawdown of -98.40%. Use the drawdown chart below to compare losses from any high point for OSUR and MED.


Loading charts...

Drawdown Indicators


OSURMEDDifference

Max Drawdown

Largest peak-to-trough decline

-90.75%

-98.40%

+7.65%

Max Drawdown (1Y)

Largest decline over 1 year

-39.37%

-37.39%

-1.98%

Max Drawdown (3Y)

Largest decline over 3 years

-74.73%

-90.91%

+16.18%

Max Drawdown (5Y)

Largest decline over 5 years

-84.23%

-96.29%

+12.06%

Max Drawdown (10Y)

Largest decline over 10 years

-90.75%

-96.76%

+6.01%

Current Drawdown

Current decline from peak

-81.76%

-96.26%

+14.50%

Average Drawdown

Average peak-to-trough decline

-56.72%

-50.87%

-5.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.46%

22.13%

-4.67%

Volatility

OSUR vs. MED - Volatility Comparison

OraSure Technologies, Inc. (OSUR) has a higher volatility of 20.12% compared to Medifast, Inc. (MED) at 10.40%. This indicates that OSUR's price experiences larger fluctuations and is considered to be riskier than MED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OSURMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.12%

10.40%

+9.72%

Volatility (6M)

Calculated over the trailing 6-month period

34.50%

31.76%

+2.74%

Volatility (1Y)

Calculated over the trailing 1-year period

48.62%

41.83%

+6.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.97%

45.28%

+9.69%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

56.94%

47.73%

+9.21%

Dividends

OSUR vs. MED - Dividend Comparison

Neither OSUR nor MED has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
MED
Medifast, Inc.
0.00%0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%
OSUR
OraSure Technologies, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

OSUR vs. MED - Financials Comparison

This section allows you to compare key financial metrics between OraSure Technologies, Inc. and Medifast, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20222023202420252026
27.93K
76.04M
(OSUR) Total Revenue
(MED) Total Revenue
Values in USD except per share items

OSUR vs. MED - Profitability Comparison

The chart below illustrates the profitability comparison between OraSure Technologies, Inc. and Medifast, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
42.3%
68.1%
Portfolio components
OSUR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, OraSure Technologies, Inc. reported a gross profit of 11.80K and revenue of 27.93K. Therefore, the gross margin over that period was 42.3%.

MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.

OSUR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, OraSure Technologies, Inc. reported an operating income of -23.18K and revenue of 27.93K, resulting in an operating margin of -83.0%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.

OSUR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, OraSure Technologies, Inc. reported a net income of -22.38K and revenue of 27.93K, resulting in a net margin of -80.1%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.


Frequently Asked Questions


OSUR and MED have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OSUR has higher volatility (20.12%) compared to MED (10.40%). In terms of maximum drawdown, OSUR dropped -90.75% vs MED's -98.40%.

OSUR currently has the higher Sharpe Ratio (0.80 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OSUR and MED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer